The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress

Pharmacology Biochemistry and Behavior

Volumn 114-115, Issue , 2013, Pages 31-36

  Yang, Wei Na ^a   Han, Hua ^a   Hu, Xiao Dan ^a   Feng, Gai Feng ^a   Qian, Yi Hua ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Cognitive impairment; Oxidative stress; Perindopril

Indexed keywords

ACETYLCHOLINESTERASE; ALUMINUM CHLORIDE; GALACTOSE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PERINDOPRIL; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; BRAIN CORTEX; CHOLINESTERASE INHIBITION; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; LEARNING; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPATIAL LEARNING; SPATIAL MEMORY; TREATMENT DURATION;

MUS;

ACETYLCHOLINESTERASE; ALZHEIMER'S DISEASE; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; PERINDOPRIL;

ACETYLCHOLINESTERASE; ALUMINUM COMPOUNDS; ANIMALS; CHLORIDES; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; GALACTOSE; GLUTATHIONE PEROXIDASE; MALE; MALONDIALDEHYDE; MICE; OXIDATIVE STRESS; PERINDOPRIL; SUPEROXIDE DISMUTASE;

EID: 84887595537     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.10.027     Document Type: Article

References (51)

1. J.R. Atack, E.K. Perry, J.R. Bonham, R.H. Perry, B.E. Tomlinson, and G. Blessed Molecular-forms of acetylcholinesterase in senile dementia of Alzheimer type-selective loss of the intermediate (10s) form Neurosci Lett 40 1983 199 204 (Pubitemid 13011162)
2. W.A. Banks, M.L. Niehoff, D. Drago, and P. Zatta Aluminum complexing enhances amyloid beta protein penetration of blood-brain barrier Brain Res 1116 2006 215 221 (Pubitemid 44508629)
3. J.M. Barnes, N.M. Barnes, B. Costall, Z.P. Horovitz, J.W. Ironside, and R.J. Naylor Angiotensin-II inhibits acetylcholine-release from human temporal cortex-implications for cognition Brain Res 507 1990 341 343 (Pubitemid 20054121)
4. A. Becaria, S.C. Bondy, and A. Campbell Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease J Alzheimers Dis 5 2003 31 38 (Pubitemid 36422849)
5. J.J. Braszko, W. Karwowska-Polecka, D. Halicka, and P.R. Gard Captopril and enalapril improve cognition and depressed mood in hypertensive patients J Basic Clin Physiol Pharmacol 14 2003 323 343 (Pubitemid 38679252)
6. D.Y. Choi, J.W. Lee, G. Lin, Y.K. Lee, Y.H. Lee, and I.S. Choi Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-kappa B signaling pathway Neurochem Int 60 2012 68 77
7. X. Cui, P. Zuo, Q. Zhang, X. Li, Y. Hu, and J. Long Chronic systemic d-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid J Neurosci Res 84 2006 647 654 (Pubitemid 44196705)
8. D. De Bundel, I. Smolders, P. Vanderheyden, and Y. Michotte Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy CNS Neurosci Ther 14 2008 315 339
9. Y.F. Dong, K. Kataoka, Y. Tokutomi, H. Nako, T. Nakamura, and K. Toyama Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease FASEB J 25 2011 2911 2920
10. O. Firuzi, and D. Pratico Coxibs and Alzheimer's disease: should they stay or should they go? Ann Neurol 59 2006 219 228 (Pubitemid 43202474)
11. Y. Gilgun Sherki, E. Melamed, and D. Offen Antioxidant treatment in Alzheimer's disease - current state J Mol Neurosci 21 2003 1 11 (Pubitemid 37204866)
12. I. Hajjar, M. Keown, and B. Frost Antihypertensive agents for aging patients who are at risk for cognitive dysfunction Curr Hypertens Rep 7 2005 466 473 (Pubitemid 43136943)
13. M. He, L. Zhao, M.J. Wei, W.F. Yao, H.S. Zhao, and F.J. Chen Neuroprotective effects of (-)-epigallocatechin-3-gallate on aging mice induced by d-galactose Biol Pharm Bull 32 2009 55 60
14. K. Herholz Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease Eur J Nucl Med Mol Imaging 35 2008 S25 S29
15. S.C. Ho, J.H. Liu, and R.Y.Y. Wu Establishment of the mimetic aging effect in mice caused by d-galactose Biogerontology 4 2003 15 18
16. D.R. Hou, Y. Wang, L. Zhou, K. Chen, Y. Tian, and Z. Song Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease Chin Med J 121 2008 2320 2323
17. H.M. Hsieh, W.M. Wu, and M.L. Hu Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer's disease in C57BL/6J mice treated with d-galactose (vol 47, pg 625, 2008) Food Chem Toxicol 47 2009 2686 2687
18. X. Hua, M. Lei, H. Ding, Q. Han, G. Hu, and M. Xiao Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with d-galactose: a potential contribution to Alzheimer's disease processes Exp Neurol 210 2008 709 718
19. H. Javed, M.M. Khan, A. Khan, K. Vaibhav, A. Ahmad, and G. Khuwaja S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type Brain Res 1389 2011 133 142
20. R.R. Kaizer, M.C. Correa, R.M. Spanevello, V.M. Morsch, C.M. Mazzanti, and J.F. Goncalves Acetylcholinesterase activation and enhanced lipid peroxidation after long-term exposure to low levels of aluminum on different mouse brain regions J Inorg Biochem 99 2005 1865 1870 (Pubitemid 41253775)
21. R.R. Kaizer, M.C. Correa, L.R.S. Gris, C.S. da Rosa, D. Bohrer, and V.M. Morsch Effect of long-term exposure to aluminum on the acetylcholinesterase activity in the central nervous system and erythrocytes Neurochem Res 33 2008 2294 2301
22. K. Kedziora Kornatowska, J. Czuczejko, K. Szewczyk Golec, J. Motyl, L. Szadujkis Szadurski, and T. Kornatowski Effects of perindopril and hydrochlorothiazide on selected indices of oxidative stress in the blood of elderly patients with essential hypertension Clin Exp Pharmacol Physiol 33 2006 751 756 (Pubitemid 44060769)
23. A. Kumar, S. Dogra, and A. Prakash Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats Behav Brain Res 205 2009 384 390
24. A. Kumar, A. Prakash, and S. Dogra Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats Pharmacol Rep 63 2011 915 923
25. R.M. Lane, S.G. Potkin, and A. Enz Targeting acetylcholinesterase and butyrylcholinesterase in dementia Int J Neuropsychopharmacol 9 2006 101 124 (Pubitemid 43068340)
26. Y. Lei, W. Fu, J. Chen, C. Xiong, G. Wu, and H. Wei Neuroprotective effects of Abacopterin E from Abacopteris penangiana against oxidative stress-induced neurotoxicity J Ethnopharmacol 134 2011 275 280
27. H.M. Luo, and F. Xiao A mouse model to be almost identical with Alzheimer's disease of the human race Neurobiol Aging 25 2004 S229
28. (3) induced mouse brain Mech Ageing Dev 130 2009 248 252
29. Z. Mao, Y.L. Zheng, Y.Q. Zhang, B.P. Han, X.W. Zhu, and Q. Chang The anti-apoptosis effects of daidzein in the brain of d-galactose treated mice Molecules 12 2007 1455 1470
30. S. McIlroy, and D. Craig Neurobiology and genetics of behavioural syndromes of Alzheimer's disease Curr Alzheimer Res 1 2004 135 142
31. M. Monczor Diagnosis and treatment of Alzheimer's disease Curr Med Chem-CNS Agents 5 2005 5 13 (Pubitemid 40392913)
32. T. Munzel, and J.F. Keaney Are ACE inhibitors a magic bullet against oxidative stress? Circulation 104 2001 1571 1574 (Pubitemid 32917353)
33. A. Musial, M. Bajda, and B. Malawska Recent developments in chotinesterases inhibitors for Alzheimer's disease treatment Curr Med Chem 14 2007 2654 2679 (Pubitemid 350048322)
34. S.M. Ravi, B.M. Prabhu, T.R. Raju, and P.N. Bindu Long-term effects of postnatal aluminium exposure on acetylcholinesterase activity and biogenic amine neurotransmitters in rat brain Indian J Physiol Pharmacol 44 2000 473 478
35. J.O. Rinne, V. Kaasinen, T. Jarvenpaa, K. Nagren, A. Roivainen, and M. Yu Brain acetylcholinesterase activity impairment and early Alzheimer's in mild cognitive disease J Neurol Neurosurg Psychiatry 74 2003 113 115 (Pubitemid 36069048)
36. S. Rossner, N. Bakinde, U. Zeitschel, R. Schliebs, and V. Bigl Cerebrospinal fluid cholinesterases-markers for loss of cholinergic basal forebrain neurons? Int J Dev Neurosci 16 1998 669 673 (Pubitemid 29151756)
37. D.B. Santos, K.C. Peres, R.P. Ribeiro, D. Colle, A.A. dos Santos, and E.L.G. Moreira Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid beta peptide in mice Exp Neurol 233 2012 767 775
38. K. Sivaprakasam Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation Curr Med Chem 13 2006 2179 2188 (Pubitemid 44132608)
39. R.C. Speth, and V.T. Karamyan The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain Heart Fail Rev 13 2008 299 309
40. 3 and d-galactose Age 31 2009 277 284
41. J. Tian, K. Ishibashi, K. Reiser, R. Grebe, S. Biswal, and P. Gehlbach Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response Proc Natl Acad Sci U S A 102 2005 11846 11851 (Pubitemid 41170813)
42. S. Tota, P.K. Kamat, G. Saxena, K. Hanif, A.K. Najmi, and C. Nath Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats Behav Brain Res 226 2012 317 330
43. J. Wang, L. Ho, L. Chen, Z. Zhao, W. Zhao, and X. Qian Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease J Clin Invest 117 2007 3393 3402 (Pubitemid 350096995)
44. O. Weinreb, T. Amit, O. Bar Am, and M.B.H. Youdim Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment Curr Drug Targets 13 2012 483 494
45. Y.F. Xian, Z.X. Lin, M. Zhao, Q.Q. Mao, S.P. Ip, and C.-T. Che Uncaria rhynchophylla ameliorates cognitive deficits induced by d-galactose in mice Planta Med 77 2011 1977 1983
46. K. Yamada, T. Horita, M. Takayama, S. Takahashi, K. Takaba, and Y. Nagata Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats Brain Res 1421 2011 110 120
47. P. Zatta, M. Ibn Lkhayat Idrissi, P. Zambenedetti, M. Kilyen, and T. Kiss In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase Brain Res Bull 59 2002 41 45
48. L. Zhang, Y. Xing, C.F. Ye, H.X. Ai, H.F. Wei, and L. Li Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside Behav Brain Res 173 2006 246 254 (Pubitemid 44291828)
49. X.L. Zhang, B. Jiang, Z.B. Li, S. Hao, and L.J. An Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose Pharmacol Biochem Behav 88 2007 64 72 (Pubitemid 47379823)
50. X. Zhang, A. Zhang, B. Jiang, Y. Bao, J. Wang, and L. An Further pharmacological evidence of the neuroprotective effect of catalpol from Rehmannia glutinosa Phytomedicine 15 2008 484 490
51. Z. Zheng, H. Chen, G. Ke, Y. Fan, H. Zou, and X. Sun Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio involvement of a mitochondria-reactive oxygen species pathway Diabetes 58 2009 954 964